Cbay stock forecast.

Analysts Offer Insights on Healthcare Companies: CymaBay Therapeutics (CBAY), Mersana Therapeutics (MRSN) and Verona Pharma (VRNA) November 8, 2023 TipRanks.Predictions of CBAY stock price for tomorrow. 14-day Premium Trial Subscription Try For Free Get FreeNov 21, 2023 · According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecasts See CymaBay Therapeutics, Inc. (CBAY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

That closing price of FOSL’s stock is at a discount of -300.0% from its 52-week high price of $6.08 and is indicating a discount of -3.29% from its 52-week low price of $1.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 360.25K if we …

Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...

Investors often compare top stocks against the Russell 3000 Index, a broad measure of the U.S. stock market comprising 3,000 large publicly traded companies or 96% of the investable U.S. equity ...Forecast . Price target. 24.08 0.00 0.00%. The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating. Based on 13 analysts giving stock ratings to CBAY in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreDec 1, 2023 · CBAY Earnings Date and Information. CymaBay Therapeutics last posted its earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.02. A price increase of 4.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 82.5% of its 52-week High-Low Range ...The Coterra stock price fell by -1.87% on the last day (Monday, 27th Nov 2023) from $26.77 to $26.27. During the last trading day the stock fluctuated 1.82% from a day low at $26.12 to a day high of $26.59. The price has been going up and down for this period, and there has been a -2.6% loss for the last 2 weeks.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

TNXP's stock price has decreased by -78.66% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for TNXP stock stock is $8.00, which predicts an increase of 1,453.40%.

Yasmeen Rahimi's average stock forecast success ratio is 24.4% with an ... CBAY CymaBay Therapeutics ENTA Enanta Pharmaceuticals ETN Eatonplc ICPT Intercept ...According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecastsAmerican ingenuity has lengthy been the driving power behind the US financial system, and few sectors embody this higher than biotech. With over 500 biotech companies working within the US, creating new medical applied sciences, drug therapies, surgical devices, and methods – the record is barely restricted by creativeness.A price increase of 4.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 82.5% of its 52-week High-Low Range ...The stock is selling for $9.87 and its $13.89 average price target suggests a 12-month upside potential of ~41%. (See CBAY stock forecast ) Cerevel Therapeutics ( CERE )Village Farms International Inc () Stock Market info Recommendations: Buy or sell Village Farms International stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Village Farms International share forecasts, stock quote and buy / sell signals below.According to present data Village Farms International's VFF shares and …Nov 3, 2023 · Cymabay Therapeutics Inc (NASDAQ:CBAY) trade information. Cymabay Therapeutics Inc (CBAY) has traded red over the past five days. The stock hit a weekly high of 16.87 this Thursday, 11/02/23. The 5-day price performance for the stock is 8.04%, and 17.06% over 30 days. With these gigs, the year-to-date price performance is 161.56%.

Get the latest information on CymaBay Therapeutics, Inc. (CBAY), a biopharmaceutical company focused on liver and other chronic diseases, including its stock price, …NextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 million.Wall Street Stock Market & Finance report, prediction for the future: You'll find the CBAK Energy Technology share forecasts, stock quote and buy / sell signals below. According to present data CBAK Energy Technology's CBAT shares and potentially its market environment have been in bearish cycle last 12 months (if exists).CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... The current average CBAY price target, as estimated by these analysts, is $0.00. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.

Cymabay Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction. ... CBAY Related stocks. Symbol 3M %Chg ; CBAY +35.42% : Cymabay Therapeutics: RDY ...View Coterra Energy Inc CTRA investment & stock information. Get the latest Coterra Energy Inc CTRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Based on analysts offering 12 month price targets for CBAY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Find real-time MCOM - micromobility.com inc stock quotes, company profile, news and forecasts from CNN Business.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Last month, Menold Daniel, the VP Finance of CBAY bought 15,500.00 shares for a total of $79,010.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than ...Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Dec 1, 2023 · 3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Cia Brasileira De Distr-pao De Acucar stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast CBD stock forecast for 2023 – 2027. Last updated: November 29, 2023. Are you interested in Companhia Brasileira de Distribuição stocks prediction? If yes, then on this page you will find useful …EBAY Regular Dividend: EBAY will begin trading ex-dividend today with a $0.25 dividend payable to shareholders of record as of 12/01/23. Quote. Profile. News. Charts. Forecasts. Financials ...See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. CBAY Stock Price Quote | Morningstar...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Verastem Inc have a median target of 33.00, with a high estimate of 36.00 and a low estimate of 17.50. The median ...LifeSci Capital analyst Patrick Dolezal has maintained their bullish stance on CBAY stock, giving a Buy rating yesterday. Patrick Dolezal has given his Buy rating due to a combination of factors ...Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comNextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 …Find real-time MCOM - micromobility.com inc stock quotes, company profile, news and forecasts from CNN Business.Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Sep 8, 2023 · CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. Dec 1, 2023 · Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price. Find real-time VSTM - Verastem Inc stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. top annuity companiesgrocery storage cabinetsotcmkts sfbqfcharles schwab competitors Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas... target wordaysteel pennie Sep 8, 2023 · CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. dodgecox The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Nov 30, 2023 · The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. ... The 29 analysts offering price forecasts for CymaBay Therapeutics have ... The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating Based on 13 analysts giving stock ratings to CBAY in the past 3 months.